Compare $KAPA vs $MTNB | Chartloom

Compare

$KAPA vs $MTNB

Kairos Pharma Ltd · Matinas BioPharma Holdings Inc

KAPA

Kairos Pharma Ltd

MTNB

Matinas BioPharma Holdings Inc

Compare $KAPA vs $MTNB

Comparing Kairos Pharma Ltd and Matinas BioPharma Holdings Inc

KAPAKairos Pharma Ltd

MTNBMatinas BioPharma Holdings Inc

KAPAKairos Pharma Ltd

Market cap

$17M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-84.1%

52W performance

-91.2%

FCF yield

-22.9%

MTNBMatinas BioPharma Holdings Inc

Market cap

$39M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-69.1%

52W performance

-89.8%

FCF yield

-16.3%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

KAPA

MTNB

Detailed metrics comparison

KAPA

Kairos Pharma Ltd

MTNB

Matinas BioPharma Holdings Inc

Market Cap

KAPA$17M

MTNB$39M

Enterprise Value

KAPA$15M

MTNB$39M

Price

KAPA$0.81

MTNB$2.87

P/E Ratio

KAPAN/A

MTNBN/A

P/S Ratio

KAPA0.00x

MTNB0.60x

EV/Sales

KAPA0.00x

MTNB0.43x

EV/EBITDA

KAPA0.00x

MTNB0.00x

P/B Ratio

KAPA1.26x

MTNB1.44x

P/FCF Ratio

KAPAN/A

MTNBN/A

EV/FCF

KAPA-3.71x

MTNB-6.00x

PEG Ratio

KAPAN/A

MTNBN/A

Forward P/E (NTM)

KAPAN/A

MTNBN/A

Forward P/S (NTM)

KAPAN/A

MTNBN/A

Revenue (TTM)

KAPA$0

MTNB$0

Revenue Growth (YoY)

KAPAN/A

MTNBN/A

Forward Rev Growth

KAPA0.0%

MTNB0.0%

Gross Margin (TTM)

KAPA0.0%

MTNB0.0%

Operating Margin (TTM)

KAPA0.0%

MTNB0.0%

EBITDA Margin (TTM)

KAPA0.0%

MTNB0.0%

Net Margin (TTM)

KAPA0.0%

MTNB0.0%

FCF Margin (TTM)

KAPAN/A

MTNBN/A

Net Income (TTM)

KAPA$-6M

MTNB$-3M

FCF (TTM)

KAPA$-4M

MTNB$-6M

EPS (TTM)

KAPA-$0.27

MTNB$0.00

ROE (TTM)

KAPA-9877.0%

MTNB-13745.0%

ROA (TTM)

KAPA-9361.0%

MTNB-9202.0%

ROIC (TTM)

KAPA-9877.0%

MTNB-13717.0%

Cash

KAPA$3M

MTNB$761K

Debt

KAPA$0

MTNB$6K

Net Cash/Debt

KAPA$3M

MTNB$755K

Current Ratio (TTM)

KAPA11.98x

MTNB0.85x

Quick Ratio (TTM)

KAPA11.46x

MTNB0.60x

Debt/Equity (TTM)

KAPA0.00x

MTNB0.00x

Debt/Assets (TTM)

KAPA0.0%

MTNB0.0%

Interest Coverage (TTM)

KAPAN/A

MTNBN/A

Net Debt/EBITDA (TTM)

KAPA0.00x

MTNB0.00x

Beta

KAPA3.30

MTNB2.20

52W Performance

KAPA-91.2%

MTNB-89.8%

YTD Performance

KAPA-84.1%

MTNB-69.1%

% from 52W High

KAPA-91.6%

MTNB-90.1%

% from 52W Low

KAPA3.5%

MTNB27.1%

Asset Turnover (TTM)

KAPA0.00x

MTNB0.09x

FCF Yield (TTM)

KAPA-22.9%

MTNB-16.3%

Earnings Yield (TTM)

KAPA-33.5%

MTNB-8.8%

Dividend Yield (TTM)

KAPAN/A

MTNBN/A

Rule of 40

KAPA0.0

MTNB0.0

EV/GP/RG

KAPAN/A

MTNBN/A

Ticker research

View KAPA research View MTNB research

Metric	KAPA Kairos Pharma Ltd	MTNB Matinas BioPharma Holdings Inc
Market & Valuation
Market Cap	$17M	$39M
Enterprise Value	$15M	$39M
Price	$0.81	$2.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.60x
EV/Sales	0.00x	0.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.26x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.71x	-6.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-3M
FCF (TTM)	$-4M	$-6M
EPS (TTM)	-$0.27	$0.00
ROE (TTM)	-9877.0%	-13745.0%
ROA (TTM)	-9361.0%	-9202.0%
ROIC (TTM)	-9877.0%	-13717.0%
Financial Health
Cash	$3M	$761K
Debt	$0	$6K
Net Cash/Debt	$3M	$755K
Current Ratio (TTM)	11.98x	0.85x
Quick Ratio (TTM)	11.46x	0.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.30	2.20
52W Performance	-91.2%	-89.8%
YTD Performance	-84.1%	-69.1%
% from 52W High	-91.6%	-90.1%
% from 52W Low	3.5%	27.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.09x
FCF Yield (TTM)	-22.9%	-16.3%
Earnings Yield (TTM)	-33.5%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KAPA research	View MTNB research

Valuation

P/S Ratio

KAPA

0.00x

MTNB

0.60x

EV/FCF

MTNB

-6.00x

KAPA

-3.71x

Growth & revenue

Forward Revenue Growth

KAPA

0.0%

MTNB

0.0%

Profitability & performance

Gross Margin

KAPA

0.0%

MTNB

0.0%

ROE

KAPA

-9877.0%

MTNB

-13745.0%

FCF Yield %

MTNB

-16.3%

KAPA

-22.9%

52-Week Performance

MTNB

-89.8%

KAPA

-91.2%

Detailed metrics comparison

KAPA

Kairos Pharma Ltd

MTNB

Matinas BioPharma Holdings Inc

Market Cap

KAPA$17M

MTNB$39M

Enterprise Value

KAPA$15M

MTNB$39M

Price

KAPA$0.81

MTNB$2.87

P/E Ratio

KAPAN/A

MTNBN/A

P/S Ratio

KAPA0.00x

MTNB0.60x

EV/Sales

KAPA0.00x

MTNB0.43x

EV/EBITDA

KAPA0.00x

MTNB0.00x

P/B Ratio

KAPA1.26x

MTNB1.44x

P/FCF Ratio

KAPAN/A

MTNBN/A

EV/FCF

KAPA-3.71x

MTNB-6.00x

PEG Ratio

KAPAN/A

MTNBN/A

Forward P/E (NTM)

KAPAN/A

MTNBN/A

Forward P/S (NTM)

KAPAN/A

MTNBN/A

Revenue (TTM)

KAPA$0

MTNB$0

Revenue Growth (YoY)

KAPAN/A

MTNBN/A

Forward Rev Growth

KAPA0.0%

MTNB0.0%

Gross Margin (TTM)

KAPA0.0%

MTNB0.0%

Operating Margin (TTM)

KAPA0.0%

MTNB0.0%

EBITDA Margin (TTM)

KAPA0.0%

MTNB0.0%

Net Margin (TTM)

KAPA0.0%

MTNB0.0%

FCF Margin (TTM)

KAPAN/A

MTNBN/A

Net Income (TTM)

KAPA$-6M

MTNB$-3M

FCF (TTM)

KAPA$-4M

MTNB$-6M

EPS (TTM)

KAPA-$0.27

MTNB$0.00

ROE (TTM)

KAPA-9877.0%

MTNB-13745.0%

ROA (TTM)

KAPA-9361.0%

MTNB-9202.0%

ROIC (TTM)

KAPA-9877.0%

MTNB-13717.0%

Cash

KAPA$3M

MTNB$761K

Debt

KAPA$0

MTNB$6K

Net Cash/Debt

KAPA$3M

MTNB$755K

Current Ratio (TTM)

KAPA11.98x

MTNB0.85x

Quick Ratio (TTM)

KAPA11.46x

MTNB0.60x

Debt/Equity (TTM)

KAPA0.00x

MTNB0.00x

Debt/Assets (TTM)

KAPA0.0%

MTNB0.0%

Interest Coverage (TTM)

KAPAN/A

MTNBN/A

Net Debt/EBITDA (TTM)

KAPA0.00x

MTNB0.00x

Beta

KAPA3.30

MTNB2.20

52W Performance

KAPA-91.2%

MTNB-89.8%

YTD Performance

KAPA-84.1%

MTNB-69.1%

% from 52W High

KAPA-91.6%

MTNB-90.1%

% from 52W Low

KAPA3.5%

MTNB27.1%

Asset Turnover (TTM)

KAPA0.00x

MTNB0.09x

FCF Yield (TTM)

KAPA-22.9%

MTNB-16.3%

Earnings Yield (TTM)

KAPA-33.5%

MTNB-8.8%

Dividend Yield (TTM)

KAPAN/A

MTNBN/A

Rule of 40

KAPA0.0

MTNB0.0

EV/GP/RG

KAPAN/A

MTNBN/A

Ticker research

View KAPA research View MTNB research

Metric	KAPA Kairos Pharma Ltd	MTNB Matinas BioPharma Holdings Inc
Market & Valuation
Market Cap	$17M	$39M
Enterprise Value	$15M	$39M
Price	$0.81	$2.87
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.60x
EV/Sales	0.00x	0.43x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.26x	1.44x
P/FCF Ratio	N/A	N/A
EV/FCF	-3.71x	-6.00x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	0.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-6M	$-3M
FCF (TTM)	$-4M	$-6M
EPS (TTM)	-$0.27	$0.00
ROE (TTM)	-9877.0%	-13745.0%
ROA (TTM)	-9361.0%	-9202.0%
ROIC (TTM)	-9877.0%	-13717.0%
Financial Health
Cash	$3M	$761K
Debt	$0	$6K
Net Cash/Debt	$3M	$755K
Current Ratio (TTM)	11.98x	0.85x
Quick Ratio (TTM)	11.46x	0.60x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	3.30	2.20
52W Performance	-91.2%	-89.8%
YTD Performance	-84.1%	-69.1%
% from 52W High	-91.6%	-90.1%
% from 52W Low	3.5%	27.1%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.09x
FCF Yield (TTM)	-22.9%	-16.3%
Earnings Yield (TTM)	-33.5%	-8.8%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View KAPA research	View MTNB research